Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Bonadonna, P. Valagussa, C. Brambilla, L. Ferrari, A. Moliterni, M. Terenziani, M. Zambetti (1998)
Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 1
D. Lerouge, E. Touboul, J. Lefranc, C. Genestie, L. Moureau-Zabotto, J. Blondon (2004)
[Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 8 3
A. Coates, A. Keshaviah, B. Thürlimann, H. Mouridsen, L. Mauriac, J. Forbes, R. Paridaens, M. Castiglione‐Gertsch, R. Gelber, M. Colleoni, I. Láng, L. Mastro, I. Smith, J. Chirgwin, J. Nogaret, T. Pieńkowski, A. Wardley, E. Jakobsen, K. Price, A. Goldhirsch (2007)
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 5
J. Sparano, Molin Wang, S. Martino, V. Jones, E. Perez, T. Saphner, A. Wolff, G. Sledge, W. Wood, N. Davidson (2008)
Weekly paclitaxel in the adjuvant treatment of breast cancer.The New England journal of medicine, 358 16
P. Cabanes, R. Salmon, J. Vilcoq, J. Durand, A. Fourquet, C. Gautier, B. Asselain (1992)
Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancerThe Lancet, 339
M. Kaufmann, G. Hortobagyi, A. Goldhirsch, S. Scholl, A. Makris, P. Valagussa, J. Blohmer, W. Eiermann, R. Jackesz, W. Jonat, A. Lebeau, S. Loibl, W. Miller, Sigfried Seeber, V. Semiglazov, Roy Smith, R. Souchon, V. Stearns, M. Untch, G. Minckwitz (2006)
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 12
Wendie Berg, Lorena Gutiérrez, Moriel Nessaiver, W. Carter, Mythreyi Bhargavan, Rebecca Lewis, Olga Ioffe, Chile, Pathol-Ogy, Assistance Program, Va Reston (2004)
Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.Radiology, 233 3
(1997)
Sono - graphic determination of cutaneous and subcutaneous fibrosis after accidental exposure to ionising radiation in the course of the Chernobyl nuclear power plant accident
(2010)
ONCOLOGY REPORTS
H. Joensuu, P. Kellokumpu-Lehtinen, P. Bono, T. Alanko, V. Kataja, R. Asola, T. Utriainen, R. Kokko, A. Hemminki, M. Tarkkanen, T. Turpeenniemi‐Hujanen, S. Jyrkkiö, M. Flander, L. Helle, S. Ingalsuo, Kaisu Johansson, A. Jääskeläinen, M. Pajunen, Mervi Rauhala, J. Kaleva-Kerola, T. Salminen, M. Leinonen, I. Elomaa, J. Isola (2006)
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.The New England journal of medicine, 354 8
Y. Ogawa, Toshiaki Takahashi, Toshihiro Kobayashi, S. Kariya, A. Nishioka, T. Ohnishi, T. Saibara, S. Hamasato, T. Tani, H. Seguchi, S. Yoshida, H. Sonobe (2003)
Apoptotic-resistance of the human osteosarcoma cell line HS-Os-1 to irradiation is converted to apoptotic-susceptibility by hydrogen peroxide: a potent role of hydrogen peroxide as a new radiosensitizer.International journal of molecular medicine, 12 6
J. Low, A. Berman, S. Steinberg, D. Danforth, M. Lippman, S. Swain (2004)
Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 20
Y. Ogawa, Toshiaki Takahashi, Toshihiro Kobayashi, S. Kariya, A. Nishioka, H. Mizobuchi, Masataka Noguchi, S. Hamasato, T. Tani, H. Seguchi, S. Yoshida, H. Sonobe (2003)
Mechanism of apoptotic resistance of human osteosarcoma cell line, HS-Os-1, against irradiation.International journal of molecular medicine, 12 4
I. Leconte, Chantal Feger, C. Galant, M. Berlière, B. Berg, W. D'Hoore, B. Maldague (2003)
Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density.AJR. American journal of roentgenology, 180 6
(2009)
Diagnostic value of fulldose FDG PET/CT for axillary lymph node staging in breast cancer patients
K. Kubota, Y. Ogawa, A. Nishioka, S. Kariya, S. Itoh, Y. Murata, N. Hamada, H. Maeda, Yohsuke Tanaka (2007)
Diagnostic accuracy of mammography, ultrasonography and magnetic resonance imaging in the detection of intraductal spread of breast cancer following neoadjuvant chemotherapy.Oncology reports, 17 4
E. Thomas, F. Holmes, T. Smith, A. Buzdar, D. Frye, G. Fraschini, S. Singletary, R. Theriault, M. Mcneese, F. Ames, R. Walters, G. Hortobagyi (2004)
The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 12
Y. Ogawa, A. Nishioka, T. Inomata, N. Yokota, T. Sasaki, M. Terashima, S. Yoshida, Y. Tanaka, N. Tohchika (1999)
Conservation treatment intensified with tamoxifen and CAF chemotherapy without axillary dissection for early breast cancer patients with clinically-negative axillary nodes.Oncology reports, 6 4
Wei-Tse Yang, W. Lam, H. Cheung, M. Suen, W. King, C. Metreweli (1997)
Sonographic, magnetic resonance imaging, and mammographic assessments of preoperative size of breast cancer.Journal of Ultrasound in Medicine, 16
M. Perloff, G. Lesnick, A. Korzun, F. Chu, J. Holland, M. Thirlwell, R. Ellison, R. Carey, L. Leone, V. Weinberg (1988)
Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 6 2
C. Louis‐Sylvestre, K. Clough, B. Asselain, J. Vilcoq, R. Salmon, F. Campana, A. Fourquet (2004)
Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 1
P. Gottlöber, M. Kerscher, H. Korting, R. Peter (1997)
Sonographic determination of cutaneous and subcutaneous fibrosis after accidental exposure to ionising radiation in the course of the Chernobyl nuclear power plant accident.Ultrasound in medicine & biology, 23 1
N. Tsuboi, Y. Ogawa, T. Inomata, D. Yoshida, S. Yoshida, T. Moriki, M. Kumon (1999)
Changes in the findings of dynamic MRI by preoperative CAF chemotherapy for patients with breast cancer of stage II and III: pathologic correlation.Oncology reports, 6 4
Y. Ogawa, Hironobu Ue, Kazuhiro Tsuzuki, M. Tadokoro, Kana Miyatake, T. Sasaki, Norikazu Yokota, N. Hamada, S. Kariya, J. Hitomi, A. Nishioka, K. Nakajima, Mitsunori Ikeda, S. Sano, T. Inomata (2008)
New radiosensitization treatment (KORTUC I) using hydrogen peroxide solution-soaked gauze bolus for unresectable and superficially exposed neoplasms.Oncology reports, 19 6
Seigo Nakamura, Hironori Kenjo, T. Nishio, T. Kazama, O. Doi, Koyu Suzuki (2002)
Efficacy of 3D-MR mammography for breast conserving surgery after neoadjuvant chemotherapyBreast Cancer, 9
(2002)
Efficacy of 3 DMR mammography for breast conserving surgery after neoadjuvant chemotherapy
Y. Ogawa, K. Kubota, Hironobu Ue, Y. Kataoka, M. Tadokoro, Kana Miyatake, Kazuhiro Tsuzuki, T. Yamanishi, S. Itoh, J. Hitomi, N. Hamada, S. Kariya, M. Fukumoto, A. Nishioka, T. Inomata (2009)
Phase I study of a new radiosensitizer containing hydrogen peroxide and sodium hyaluronate for topical tumor injection: a new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II).International journal of oncology, 34 3
Y. Hata, Y. Ogawa, A. Nishioka, T. Inomata, S. Yoshida (1998)
Thin section computed tomography in the prone position for detection of axillary lymph node metastases in breast cancer.Oncology reports, 5 6
T. Kobayashi (1984)
Ultrasonic tissue characterization.Journal belge de radiologie, 67 4
R. Rouzier, J. Extra, M. Carton, M. Falcou, A. Vincent-Salomon, A. Fourquet, Pierre Pouillart, E. Bourstyn (2001)
Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 18
Y. Ogawa, Toshiaki Takahashi, Toshihiro Kobayashi, S. Kariya, A. Nishioka, S. Hamasato, T. Moriki, H. Seguchi, S. Yoshida, H. Sonobe (2004)
Immunocytochemical characteristics of human osteosarcoma cell line HS-Os-1: possible implication in apoptotic resistance against irradiation.International journal of molecular medicine, 14 3
B. Fisher, C. Redmond, E. Fisher (1980)
The contribution of recent nsabp clinical trials of primary breast cancer therapy to an understanding of tumor biology—an overview of findingsCancer, 46
L. Esserman, N. Hylton, L. Yassa, Jonathan Barclay, S. Frankel, E. Sickles (1999)
Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 1
L. Esserman, N. Hylton, T. George, N. Weidner (1999)
Contrast‐Enhanced Magnetic Resonance Imaging to Assess Tumor Histopathology and Angiogenesis in Breast CarcinomaThe Breast Journal, 5
G. Bianchini, G. Salgarello, T. Mennini, G. Lorini (1969)
[Intra-arterial infusion of hydrogen peroxide in radiotherapy of malignant tumors].La Radiologia medica, 55 3
T. Hata, Hiromasa Takahashi, Kenichi Watanabe, M. Takahashi, K. Taguchi, T. Itoh, S. Todo (2004)
Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography.Journal of the American College of Surgeons, 198 2
Y. Ogawa, A. Nishioka, T. Inomata, T. Ohnishi, S. Kariya, M. Terashima, S. Yoshida, N. Tohchika, Y. Tanaka, M. Kumon (2000)
Conservation treatment intensified with an anti-estrogen agent and CAF chemotherapy for stage I and II breast cancer.Oncology reports, 7 3
P. Therasse, S. Arbuck, E. Eisenhauer, J. Wanders, R. Kaplan, L. Rubinstein, J. Verweij, M. Glabbeke, A. Oosterom, M. Christian, S. Gwyther (2000)
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.Journal of the National Cancer Institute, 92 3
E. Bäz, H. Madjar, C. Reuss, M. Vetter, B. Hackelöer, K. Holz (2000)
The role of enhanced Doppler Ultrasound in differentiation of benign vs. malignant scar lesion after breast surgery for malignancyUltrasound in Obstetrics and Gynecology, 15
W. Chasin, C. Gross, C. Wang, D. Miller (1967)
Hydrogen peroxide and irradiation of tumors.Archives of otolaryngology, 85 2
T. Heusner, S. Kuemmel, S. Hahn, A. Koeninger, F. Otterbach, M. Hamami, Klaus Kimmig, M. Forsting, A. Bockisch, G. Antoch, A. Stahl (2009)
Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 36
M. Goethem, K. Schelfout, L. Dijckmans, J. Auwera, J. Weyler, I. Verslegers, I. Biltjes, A. Schepper (2004)
MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasoundEuropean Radiology, 14
M. Delena, M. Varini, R. Zucali, D. Rovini, G. Viganotti, P. Valagussa, U. Veronesi, G. Bonadonna (1981)
Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgery.Cancer clinical trials, 4 3
M. Adams, S. Lipshultz, C. Schwartz, L. Fajardo, V. Coen, L. Constine (2003)
Radiation-associated cardiovascular disease: manifestations and management.Seminars in radiation oncology, 13 3
(2002)
UICC: TNM Classification of Malignant Tumors. 6th edition
We have previously developed a new enzyme-targeting radiosensitization treatment named Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II), which markedly enhances radiotherapeutic effects on various types of locally advanced malignant neoplasms. KORTUC II was approved by our local ethics committee for use against various types of malignant neoplasms. A maximum of 6 ml of radiosensitizer was injected into tumor tissue under ultrasonographic guidance just before each administration of radiotherapy. Seventeen patients with locally advanced breast cancer were enrolled to receive KORTUC II with systemic chemotherapy without surgical care. Patients were eligible if they had declined surgical treatment. Median observation period was 13.4 months (range, 1-26 months). This therapy was well tolerated. Contrast-enhanced magnetic resonance imaging revealed complete response in all primary breast tumors, and no patients displayed local recurrence during the follow-up period. Ultrasonography depicted tumor-like findings in 9 of 17 cases after therapy. The existence rate of posterior shadow artifacts behind the tumor was 2/17 before therapy, increasing to 8/17 after therapy. Intratumoral flow signals on color Doppler sonography were seen in 16/17 cases before therapy, but had disappeared from all cases after therapy. The increased rate of posterior shadow artifacts and absence of flow signals after therapy suggest that the tumor-like finding on ultrasonography represents scar tissue. Computed tomography revealed positive axillary nodes metastases in 16/17 and 2/17 cases before and after therapy, respectively. Nodal metastatic failure affected only 1 patient, who refused adjuvant systemic chemotherapy at the end of the observation period. Abnormal lymph node findings on computed tomography remained stable in the other patient. Excellent locoregional control based on accurate radiological evaluation implies that KORTUC II with chemotherapy has the potential to replace surgery in therapy for locally advanced breast cancer.
Oncology Reports – Spandidos Publications
Published: Nov 1, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.